-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, BASF and Clayton, Dubilier & Rice signed an agreement to sell Solenis to Platinum Equity
.
The transaction means that Solenis’ corporate value is US$5.
It is reported that Platinum Capital is a private equity company established in California in 1995
.
Since February 1, 2019, BASF holds 49% of Solenis shares and calculates its share in Solenis in accordance with the equity method; 51% of the shares are managed by funds managed by Ceduris and Solenis.
As part of the transaction, BASF and Kedurer will completely withdraw their investment in Solenis
.
The transaction does not affect any existing medium and long-term supply agreements and commercial relationships between BASF and Solenis